European stocks jumped to a record high on Wednesday powered by heavyweight technology and healthcare stocks, with markets ...

Europe’s Stoxx 600 index hit a record high for the first time since September, as investors grew optimistic that the harshest ...

European equities rose on Tuesday on relief that US President Donald Trump had refrained from immediately targeting the ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novo ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...